Cellular protein identified as possible drug target to combat Lassa hemorrhagic fever Experimental approach could uncover new treatment options for the virus, which is highly prevalent in Western Africa.
July 20, 2022
La Jolla, CA Scripps Research in collaboration with the La Jolla Institute for Immunology have used a novel strategy to identify and study host cell proteins that contribute to multiplication of Lassa virus, a virus that causes a severe hemorrhagic fever disease. The discovery could lead to potential new drug targets for treating the disease.
Lassa virus (LASV) is highly prevalent in Western Africa. The virus is typically transmitted to humans via contact with aerosols or the droppings and secretions of infected rodents. Infected individuals can develop Lassa fever (LF), a hemorrhagic fever disease associated with high morbidity and mortality. Notably, many LF survivors experience long-term side effects including sensory-neural hearing loss. Other than off-label use of ribavirin which is of limited and controversial efficacy there are no treatments for LF, nor any licensed vaccines.
The research, led by Juan Carlos de la Torre, PhD, of Scripps Research, in collaboration with the laboratory of Erica Ollmann Saphire, PhD, at La Jolla Institute for Immunology, was published in the Proceedings of the National Academy of Sciences (PNAS) on July 18, 2022.
To identify host cell proteins that contribute to LASV replication, the researchers implemented a new strategy that combined proximity proteomics with the use of a non-infectious cell-based LASV minigenome system that recreates the molecular processes involved in LASV replication. Proximity proteomics fuses a protein of interest to an enzyme that will label nearby proteins with a chemical tag, which facilitates their identification.
Viruses dont operate in isolation, says Saphire. They hijack and require molecules of the cell for their own purposes.
De la Torre compares the process to the way social networks can leave traces of interactions and provide information about how people might relate to one another, for example, whether two users are located in the same city or household, or if they are family members or acquaintances.
Just as with social media users, some interactions between proteins make sense, and you can infer relationships between the two, he says. Other protein interactions are casual or accidental and don't mean anything, but, for many others, further investigation is required to uncover their biological implications.
With this combined approach, they were able to identify 42 cellular proteins likely to play a role in the replication and spread of LASV. One of the identified host proteins GSPT1 might be a potential drug target, as CC-90009, a drug that specifically targets and degrades GSPT1, exhibited antiviral activity against LASV without cytotoxicity. CC-90009 is currently in phase 1 clinical development for the treatment of acute myeloid leukemia, raising the possibility of its repurposing as an antiviral against LASV.
De la Torre notes that because this method of identifying viral-host cell protein interactions of interest can be done without the live, infectious LASV, this strategy does not require a biosafety level 4 (BSL4) lab, which are expensive to operate.
We think the experimental approach we used could be a rubric for any other highly pathogenic virus , he says. You would have to change the components, but conceptually, the same approach could potentially be applied with any highly pathogenic virus requiring BSL4.
Furthermore, says de la Torre, the identification of host cell proteins that are required for LASV replication can facilitate the repurposing of drugs currently being used for other indications as antivirals against LASV.
This provides an advantage, he says, since diseases like Ebola and Lassa are restricted to certain geographical areas, making it unlikely pharmaceutical companies will develop drugs specifically for them. Notably, Lassa and Ebola share a number of host cell proteins, which may facilitate the development of broad-spectrum antivirals by targeting host factors used by these two viruses.
He notes that a better treatment for LASV could also have an impact outside of Western Africa, as increased traveling to and from LASV endemic regions has resulted in the importation of LF cases into metropolitan areas outside Western Africa.
People doing humanitarian aid in Western Africa, whether clinical work or social work, can get exposed, return to their home and then develop symptoms, he says. What happens in many countries outside of Western Africa is that doctors who are not familiar with LF assume the disease is malaria and treat for that. When that doesn't work, by the time they realize what the disease is, it's usually too late.
Jingru Fang, Haydar Witwit, George Tsaprailis, and Gogce Crynen of Scripps Research are co-contributing authors of Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antivirals.
This research was supported by institutional 423 funds of La Jolla Institute of Immunology and NIH/NIAID grants AI125626 and AI128556.
Infectious Diseases de la Torre, Juan Carlos
Most recent headlines
09/11/2025
Dalet today announced a transformative leap forward for media operations: Agentic Artificial Intelligence (AI) that unifies the Dalet ecosystem under one natura...
22/10/2025
Prime Video Inks Deal To Present NFL Black Friday Game Worldwide By SVG Staff
Wednesday, October 22, 2025 - 10:06 am
Print This Story | Subscribe
Story ...
22/10/2025
NBA Tip-Off: ESPN Goes 1080p HDR End-to-End, Flipping HDR Switch on REMI and REM...
22/10/2025
FloSports Empowers Division II, III Athletic Departments With Turnkey Production...
22/10/2025
Wall Street Video Summit Debuts, Bringing Together 200 Financial Enterprise Vide...
22/10/2025
Dueling Pianos: International Chopin Piano Competition Is as Competitive as a Ba...
22/10/2025
In 1995, a young Colombian artist released an album that would change Latin pop ...
22/10/2025
Over the past few months, a photovoltaic system has been installed on a three-he...
22/10/2025
The Orion spacecraft for NASA's Artemis II mission is stacked on the Space Launch System (SLS) rocket in High Bay 3 of the Vehicle Assembly Building at Kenn...
22/10/2025
L3Harris' Hybrid SATCOM is resilient by design, offering path diversity that eliminates vulnerabilities by routing data across the best available networks i...
22/10/2025
WASHINGTON, D.C. Organizers of NAB Show New York said they are expecting more than 12,000 registered attendees from about 100 countries along with 260 exhibitor...
22/10/2025
WASHINGTON, D.C The organizers of The 2025 NAB Show New York have announced that they are expecting more than 12,000 registered attendees from about 100 countr...
22/10/2025
Masque Sound, a leading theatrical sound reinforcement, installation and design company, supplied an extensive gear package of professional-grade equipment for ...
22/10/2025
Lightware, a global leader in signal management and AV connectivity solutions, is seeing strong market momentum for the UCX-3x3-TPX-RX20, a compact transmitter-...
22/10/2025
MELVILLE, N.Y. Chyron has released PAINT 10.2, the latest update for its telestration platform, adding support for SMPTE ST 2110 IP workflows, expanding brandin...
22/10/2025
WASHINGTON Run3TV today said NBCUniversal is joining as an investor in the ATSC 3.0 Framework Authority, which develops the Run3TV NextGen TV application platfo...
22/10/2025
ATLANTA swXtch.io will feature two new networking solutions extending the company's reach across more cloud and on-prem workflows at NAB Show New York, set ...
22/10/2025
The Warner Bros. Discoverys HBO Max streaming services has increased prices for all its streaming tiers effectively immediately for new customers. Existing cust...
22/10/2025
LOS ANGELES OpenDrives has signed a new distribution partnership deal with Versatile Distribution Services (VDS) to strengthen its channel and streamline how it...
22/10/2025
WASHINGTON, D.C The organizers of The 2025 NAB Show New York have announced that they are expecting more than 12,000 registered attendees from about 100 countr...
22/10/2025
Samora Pinderhughes Brings Immersive Sound to Berklee's Signature Series The artist and composer, who's worked with Herbie Hancock, Robert Glasper, Co...
22/10/2025
BMI Day at Berklee Celebrates Composer Fil Eisler and Awards Scholarship to Stud...
22/10/2025
October 22nd, 2025 TRIBECA ANNOUNCES STAR-STUDDED LINEUP OF MEMBERSHIP EVENTS F...
22/10/2025
Rohde & Schwarz and TRUMPF cooperate in drone defense Rohde & Schwarz and TRUMPF partner to deliver a comprehensive drone defense solution combining Rohde & S...
22/10/2025
European Broadcaster Upgrades To Grass Valley's NativeIP LDX 135 Cameras And...
22/10/2025
Everyone Gets a Better Deal on Verizon with New FOX One Perk The $15 FOX One streaming service perk is yet another way Verizon continues to add savings for cu...
22/10/2025
First Look Hidden Assets Series 3
Premieres on 9th November 9:30pm on RT One & RT Player
WATCH HERE Promo Link: Hidden Assets Series 3 | RT
The Crimin...
21/10/2025
NAB New York 2025: Although AES Show Is on Its Own, Audio Will Be a Major Part o...
21/10/2025
NAB New York 2025: Business of Broadcast and Media,' Future of Content'...
21/10/2025
SVG All-Stars: Ethan Folz, Senior Director, Digital Operations and Quality of Ex...
21/10/2025
NBA on NBC/Peacock: Livestream Offers Graphic Overlays, Predictive Gaming, Ancil...
21/10/2025
NBA on NBC/Peacock: At the Front Bench With Producer Frank DiGraci and Director ...
21/10/2025
NBA on NBC/Peacock: NBC Sports, NEP Build Ultra-Flexible Production Plan That Se...
21/10/2025
Indigenous storytelling has been at the heart of the work of the Sundance Instit...
21/10/2025
Top L-R: Mysterious Skin, American Dream Second Row L-R: Little Miss Sunshine, D...
21/10/2025
Last week, Spotify and Columbia Records transformed Pier 4 at the Brooklyn Army ...
21/10/2025
SBS Learn's Dharug Ngurra resource empowers classrooms to meaningfully celeb...
21/10/2025
As global operators simplify and evolve their digital platforms, NPS improvement...
21/10/2025
Critical Design Review completion is a key milestone on the path toward Wideband Global Satellite Communications certification for the network in 2026, opening ...
21/10/2025
New Australian undersea training range to implement and improve warfighting tactics, proficiency and safety; enable joint/allied training that contributes to pr...
21/10/2025
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({...
21/10/2025
September, the beginning of autumn, brought an expected revival to the TV market, largely due to the new fall TV schedules. The time spent in front of the TV sc...
21/10/2025
Broadcast Booms with 20% Uptick vs. August, Achieving Largest Monthly
Increase ...
21/10/2025
During September, streaming's share of TV viewing in Mexico settled at 24.5%, a marginal shift of -0.5 share points from the previous month.
Disclaimer: YU...
21/10/2025
RENNES, France BBright and GlobalM have conducted a technical trial validating Ultra HD interoperability across the entire contribution chain in the cloud, achi...
21/10/2025
Kokusai Denki Electric America will mark the U.S. debut of a new 4K camera at the 2025 NAB New York, Oct. 22-23. Now available, the Z-HD6500-S1 UHD/HD productio...
21/10/2025
Triveni Digital, a trusted leader in ATSC 1.0 and 3.0 service delivery, data broadcasting, and quality assurance solutions, will showcase its entire NEXTGEN TV ...
21/10/2025
Radio Azzurra FM, longest-running radio station in the province of Novara, northwest Italy, has invested in an DHD SX2 audio routing and mixing console for inte...
21/10/2025
Globecast, the leading provider of broadcast, media and entertainment managed services, has announced the appointment of G Morgan as Executive Vice President of...
Cellular protein identified as possible drug target to combat Lassa hemorrhagic fever Experimental approach could uncover new treatment options for the virus, which is highly prevalent in Western Africa.
